Biote Corp.
About Biote Corp.
Products & Services
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Secondary Offering T: - FT: Secondary Offering |
A: 27912947 MR: - FA: $27,912,947.20 FAN: 27912947 |
D: 2023-06-05 FD: 2023-06-05 |
1 investors |
| 2 |
RT: Secondary Offering T: - FT: Secondary Offering |
A: 25500000 MR: - FA: $25,500,000 FAN: 25500000 |
D: 2023-01-09 FD: 2023-01-09 |
3 investors |
| 3 |
RT: Secondary Offering T: - FT: Secondary Offering |
A: 22173915 MR: - FA: $22,173,915 FAN: 22173915 |
D: 2023-01-05 FD: 2023-01-05 |
3 investors |
Growth Metrics
Team & Leadership
Gary Donovitz
MD, FACOG
Mickey Karram
Board Chair
Cory Rice
Chief Clinical Advisor
Bruce Dorr
Senior Medical Advisor
Lisa Jukes
M.D.
Peter Castillo
Fellowship-trained Female Pelvic Medicine specialist
Recent News
Biote Corp. Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- biote.com
- Industries
- Healthcare
- Company Size
- ~360 employees (est.)
Technology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro